Unknown

Dataset Information

0

Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.


ABSTRACT: Nebulization is currently used for delivery of antibiotics for respiratory infections. Bacteriophages (or phages) are effective predators of pathogens including Pseudomonas aeruginosa commonly found in the lungs of patients with cystic fibrosis (CF). It is known that phages and antibiotics can potentially show synergistic antimicrobial effect on bacterial killing. In the present study, we investigated synergistic antimicrobial effect of phage PEV20 with five different antibiotics against three P. aeruginosa strains isolated from sputum of CF patients. The antibiotics included ciprofloxacin, tobramycin, colistin, aztreonam and amikacin, which are approved by U.S Food and Drug Administration (FDA) for inhaled administration. Phage and antibiotic synergy was determined by assessing bacterial killing performing time-kill studies. Among the different phage-antibiotic combinations, PEV20 and ciprofloxacin exhibited the most synergistic effect. Two phage-ciprofloxacin combinations, containing 1/4 and 1/2 of the minimum inhibitory concentration (MIC) of ciprofloxacin against P. aeruginosa strains FADD1-PA001 (A) and JIP865, respectively were aerosolized using both air-jet and vibrating mesh nebulizers and the synergistic antibacterial activity was maintained after nebulization. Air-jet nebulizer generated droplets with smaller volume median diameters (3.6-3.7?µm) and slightly larger span (2.3-2.4) than vibrating mesh nebulizers (5.1-5.3?µm; 2.1-2.2), achieving a higher fine particle fraction (FPF) of 70%. In conclusion, nebulized phage PEV20 and ciprofloxacin combination shows promising antimicrobial and aerosol characteristics for potential treatment of respiratory tract infections caused by drug-resistant P. aeruginosa.

SUBMITTER: Lin Y 

PROVIDER: S-EPMC6174101 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5388299 | BioStudies
2019-01-01 | S-EPMC6768630 | BioStudies
1000-01-01 | S-EPMC6301902 | BioStudies
2019-01-01 | S-EPMC6783858 | BioStudies
2020-01-01 | S-EPMC7479825 | BioStudies
2014-01-01 | S-EPMC4068605 | BioStudies
2020-01-01 | S-EPMC7142802 | BioStudies
2019-01-01 | S-EPMC6901909 | BioStudies
2019-01-01 | S-EPMC6710527 | BioStudies
2019-01-01 | S-EPMC6550368 | BioStudies